Janet Shimotake, MD
Associate Professor
Pediatrics
School of Medicine

Education & Training

Show all (4) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2019
• Fellowship in Neonatal and Perinatal Medicine University of California, San Francisco 07/2009
• Pediatrics Residency University of Chicago Comer Children's Hospital 06/2003
• MD University of Chicago, Pritzker SOM 06/1999

Publications (2)

Top publication keywords:
PyrrolesVascular Endothelial Growth Factor Receptor-2Hematopoietic Stem Cell TransplantationAnimals, NewbornIndolesCalpainInfarction, Middle Cerebral ArteryCerebral ArteriesCaspase 3StrokeEndothelial Cellsalpha-ThalassemiaNecrosisAngiogenesis InhibitorsNeovascularization, Physiologic

• In utero hematopoietic cell transplantation in fetuses with α-thalassemia major: a phase 1 clinical trial.
  Blood advances 2026 MacKenzie TC, Lianoglou BR, Gonzalez Velez J, Dvorak CC, Kharbanda S, Herzeg A, Canepa E, Kreger EM, Frascoli M, Sper R, Gupta AR, Leung J, Tang Q, Sinha R, Worthington AK, Gano D, Bakkour Coco S, …
• Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke.
  Stroke 2010 Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero DM